<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02320669</url>
  </required_header>
  <id_info>
    <org_study_id>14798</org_study_id>
    <secondary_id>R01FD004362-01A2</secondary_id>
    <nct_id>NCT02320669</nct_id>
  </id_info>
  <brief_title>Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass</brief_title>
  <acronym>TRICC-2</acronym>
  <official_title>Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seattle Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine
      (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease
      during cardiopulmonary bypass surgery. Funding Source - FDA OOPD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time To Extubation</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU Length of Stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge on Oral Feeds</measure>
    <time_frame>30 days</time_frame>
    <description>Whether or not patient is discharged on oral feeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality (if applicable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of freedom from Extracorporeal Membrane Oxygenation (ECMO) - if applicable</measure>
    <time_frame>30 days</time_frame>
    <description>start of ECMO (if applicable) meets this secondary endpoint, indicates significant patient regression for inpatient status post-operatively.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Congenital Heart Defects</condition>
  <arm_group>
    <arm_group_label>Triostat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active Medication - Synthetic Thyroid Hormone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triostat</intervention_name>
    <description>Bolus of Triiodothyronine followed by infusion for 48 hours</description>
    <arm_group_label>Triostat</arm_group_label>
    <other_name>triiodothyronine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Bolus of Placebo followed by infusion for 48 hours</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Informed consent obtained

          2. Male and female patients &lt;5 months (152 days) of age

          3. Patients undergoing cardiopulmonary bypass

        Exclusion Criteria:

          1. Known thyroid disease (Down Syndrome is not an exclusion criterion unless patient has
             thyroid disease)

          2. Trisomy 13 and 18

          3. Prolonged preoperative ventilator support which would not be impacted by cardiac
             surgery (Lung disease: bronchopulmonary dysplasia, hypoplastic lungs associated with
             diaphragmatic hernia)

          4. Any other condition as determined by the PI causing prolonged ventilator support which
             is unlikely to respond favorably to cardiac surgery

          5. Prior participation in the clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Portman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seattle Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Portman, MD</last_name>
    <phone>206-987-1014</phone>
    <email>michael.portman@seattlechildrens.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Cox, MASc</last_name>
    <phone>206-884-5153</phone>
    <email>Jennifer.Cox@seattlechildrens.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Los Angeles Children's Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Hastings, MD</last_name>
      <email>LHastings@chla.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Beatriz Ornelas, MA MBA CCRP</last_name>
      <phone>323-361-4914</phone>
      <email>bornelas@chla.usc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Laura Hastings, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lucille Packard Children's Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Roth, MD</last_name>
      <phone>650-725-8349</phone>
      <email>sroth@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sara Sherman-Levine, MSN CPNP FNP</last_name>
      <phone>650-862-7067</phone>
      <email>sarapnp@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Roth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer A Cox, MASc</last_name>
      <phone>206-884-5153</phone>
      <email>Jennifer.Cox@seattlechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Michael A Portman, MD</last_name>
      <phone>206-987-1014</phone>
      <email>michael.portman@seattlechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Portman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2014</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seattle Children's Hospital</investigator_affiliation>
    <investigator_full_name>Michael Portman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

